The Global Achondroplasia Treatment Market Is Witnessing High Demand Owing To the Rise of the Condition and the Focus of the Key Market Players on Discovering Advanced Medical Technologies
The main goals of achondroplasia treatment are reduction in hypertrophy, sparing of bone formation, prevention of secondary fractures, and normalization of growth. Achondroplasia treatment options for this disease include surgical procedures, drug therapy including metformin, combination therapy with anti-angiogenesis drugs, and anti-ischemia drugs such as topical immunomodulators. Drug therapy is used mainly to suppress the activity of human growth hormone (HGH), which is responsible for the increased rate of growth in a human fetus. Other drugs used include insulin, oral hypoglycemic agents, calcium channel blockers, oral stimulants, anti-cancer drugs, steroidal compounds androgens, and aminophylline. Surgical achondroplasia treatment can be performed for three major reasons, namely, long-standing deformity caused due to short stature or congenital short stature, correction of joint deformities caused due to malformation of the vertebrae, and correction of short stature. In most...